Cooper Net Profit Margin 2010-2024 | COO
Current and historical net profit margin for Cooper (COO) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Cooper net profit margin for the three months ending January 31, 2024 was .
| Cooper Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2024-01-31 |
$3.67B |
$0.29B |
7.94% |
| 2023-10-31 |
$3.59B |
$0.30B |
8.21% |
| 2023-07-31 |
$3.51B |
$0.28B |
7.85% |
| 2023-04-30 |
$3.43B |
$0.29B |
8.43% |
| 2023-01-31 |
$3.38B |
$0.38B |
11.12% |
| 2022-10-31 |
$3.31B |
$0.39B |
11.67% |
| 2022-07-31 |
$3.22B |
$0.43B |
13.36% |
| 2022-04-30 |
$3.14B |
$0.95B |
30.20% |
| 2022-01-31 |
$3.03B |
$0.94B |
31.00% |
| 2021-10-31 |
$2.92B |
$2.95B |
100.75% |
| 2021-07-31 |
$2.85B |
$2.92B |
102.46% |
| 2021-04-30 |
$2.66B |
$2.36B |
88.50% |
| 2021-01-31 |
$2.47B |
$2.25B |
91.20% |
| 2020-10-31 |
$2.43B |
$0.24B |
9.83% |
| 2020-07-31 |
$2.44B |
$0.28B |
11.43% |
| 2020-04-30 |
$2.54B |
$0.34B |
13.53% |
| 2020-01-31 |
$2.67B |
$0.45B |
17.00% |
| 2019-10-31 |
$2.65B |
$0.47B |
17.57% |
| 2019-07-31 |
$2.61B |
$0.45B |
17.07% |
| 2019-04-30 |
$2.59B |
$0.43B |
16.46% |
| 2019-01-31 |
$2.57B |
$0.37B |
14.24% |
| 2018-10-31 |
$2.53B |
$0.14B |
5.53% |
| 2018-07-31 |
$2.44B |
$0.13B |
5.24% |
| 2018-04-30 |
$2.34B |
$0.13B |
5.60% |
| 2018-01-31 |
$2.23B |
$0.18B |
7.85% |
| 2017-10-31 |
$2.14B |
$0.37B |
17.48% |
| 2017-07-31 |
$2.10B |
$0.35B |
16.51% |
| 2017-04-30 |
$2.06B |
$0.33B |
16.06% |
| 2017-01-31 |
$2.02B |
$0.30B |
14.82% |
| 2016-10-31 |
$1.97B |
$0.27B |
13.92% |
| 2016-07-31 |
$1.91B |
$0.25B |
13.12% |
| 2016-04-30 |
$1.85B |
$0.21B |
11.18% |
| 2016-01-31 |
$1.80B |
$0.19B |
10.76% |
| 2015-10-31 |
$1.80B |
$0.20B |
11.35% |
| 2015-07-31 |
$1.81B |
$0.20B |
10.94% |
| 2015-04-30 |
$1.78B |
$0.24B |
13.54% |
| 2015-01-31 |
$1.76B |
$0.26B |
14.74% |
| 2014-10-31 |
$1.72B |
$0.27B |
15.73% |
| 2014-07-31 |
$1.66B |
$0.30B |
17.82% |
| 2014-04-30 |
$1.64B |
$0.30B |
18.10% |
| 2014-01-31 |
$1.61B |
$0.29B |
18.16% |
| 2013-10-31 |
$1.59B |
$0.30B |
18.64% |
| 2013-07-31 |
$1.57B |
$0.31B |
19.78% |
| 2013-04-30 |
$1.54B |
$0.29B |
18.79% |
| 2013-01-31 |
$1.50B |
$0.27B |
17.95% |
| 2012-10-31 |
$1.45B |
$0.25B |
17.23% |
| 2012-07-31 |
$1.41B |
$0.23B |
16.60% |
| 2012-04-30 |
$1.38B |
$0.21B |
15.26% |
| 2012-01-31 |
$1.36B |
$0.19B |
14.01% |
| 2011-10-31 |
$1.33B |
$0.18B |
13.16% |
| 2011-07-31 |
$1.28B |
$0.17B |
12.95% |
| 2011-04-30 |
$1.23B |
$0.16B |
13.20% |
| 2011-01-31 |
$1.19B |
$0.13B |
11.00% |
| 2010-10-31 |
$1.16B |
$0.11B |
9.67% |
| 2010-07-31 |
$1.13B |
$0.09B |
8.33% |
| 2010-04-30 |
$1.12B |
$0.08B |
6.80% |
| 2010-01-31 |
$1.09B |
$0.10B |
8.91% |
| 2009-10-31 |
$1.08B |
$0.10B |
9.35% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$17.657B |
$3.593B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
